The MIND (Maximizing Innovation in Neuroscience Discovery) Prize funded by the Pershing Square Foundation (PSF) supports early-to-mid-career investigators working with Neurodegenerative Diseases (NDDs). This prize focuses on research domains that may include, but are not limited to, neurobiology, brain imaging and mapping, machine learning, drug delivery, and synthetic biology. Applicants must have MD, PhD, or MD-PhD degree (or equivalent) and must have completed at least one but no more than ten years of independent research experience by the start date of the Prize (May 2023). Principal Investigators must hold faculty appointments at academic research institutions in the U.S.A. Applicants who are not U.S. citizens or permanent residents, must have sufficient time to complete the project and grant term within the U.S with their visa.
The recipients will be funded 250,000 USD/year for three years and will become a part of the unique network of researchers associated with PSF. No more than 10% of the award amount will be allocated to indirect costs.
LOIs are due on Monday, December 12, 2022, by 5 pm EST. Upon selection, the finalists will be invited to present their proposal at the 2023 MIND Prize Review Board Meeting in Manhattan, New York on February 27, or February 28, 2023.
Menu
